This website provides information on patients with mutations in the Lectin, Mannose binding 2 like (LMAN2L) gene, including clinical data, molecular data, management and research options.

The syndrome caused by mutations in the Lectin, Mannose binding 2 like (LMAN2L) gene is a multisystem disorder characterized by: Intellectual disability, Seizures (Epilepsy), Speech delay/absent, Aggressive behaviour

Not all individuals with a mutation in the Lectin, Mannose binding 2 like (LMAN2L) gene have these features.

This website was created to share and collect information about clinic, management and research projects to gather more knowledge and provide better treatment of patients with mutations in the Lectin, Mannose binding 2 like (LMAN2L) gene.

Rafiullah Rafiullah, MS, PhD Human Molecular Genetics, University of Heidelberg, Germany, Scientist at King Faisal Specialist Hospital and Research Center, Holding Company, Riyadh, Kingdom of Saudi Arabia, rafiullahr@sdl.com.sa, rafi_tareen@yahoo.com

Hazrat Ali Khan, MBBS, FCPS, Assistant Professor Psychiatry, Balochistan Institute of Psychiatry and Behavioral Sciences – BIPBS, Quetta, Pakistan, Facilitator Communication Skill, at College of Physicians and Surgeons Pakistan, Quetta, Pakistan, Halia73@hotmail.com